Olink Proteomics Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
707
- Latest Deal Type
-
M&A
- Financing Rounds
-
10
- Investments
-
1
Olink Proteomics General Information
Description
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions.
Contact Information
Website
www.olink.com(Operating Subsidiary)
Corporate Office
- Salagatan 16F
- 753 30 Uppsala
- Sweden
Corporate Office
- Salagatan 16F
- 753 30 Uppsala
- Sweden
Olink Proteomics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Olink Proteomics Comparisons
Industry
Financing
Details
Olink Proteomics Competitors (13)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
Oxford BioMedica | Corporation | Oxford, United Kingdom | ||||
Luminex | Corporate Backed or Acquired | Austin, TX | ||||
Harvard Bioscience | Formerly PE-Backed | Holliston, MA | ||||
Molecular Devices | Corporate Backed or Acquired | San Jose, CA |
Olink Proteomics Patents
Olink Proteomics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240280579-A1 | Methods and systems for presenting differential protein expressions on a grid | Pending | 21-Feb-2023 | ||
GB-202018503-D0 | Analyte detection method employing concatamers | Inactive | 25-Nov-2020 | ||
US-20220162589-A1 | Analyte detection method employing concatemers | Pending | 25-Nov-2020 | ||
AU-2021388789-A1 | Analyte detection method employing concatemers | Pending | 25-Nov-2020 | ||
EP-4251762-A1 | Analyte detection method employing concatemers | Pending | 25-Nov-2020 | C12Q1/6806 |
Olink Proteomics Executive Team (25)
Name | Title | Board Seat |
---|---|---|
Jon Heimer | Chief Executive Officer & Board Member | |
Oskar Hjelm | Chief Financial Officer | |
Anna Marsell | Chief Operating Officer | |
Fredrik Netzel | Chief Operating Officer | |
Rickard El Tarzi | Chief Strategy Officer |
Olink Proteomics Board Members (18)
Name | Representing | Role | Since |
---|---|---|---|
Self | Board Member | ||
Olink Proteomics | Chief Executive Officer & Board Member | ||
Self | Chairman & Board Member | ||
Self | Board Member | ||
Self | Board Member |
Olink Proteomics Signals
Olink Proteomics Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Olink Proteomics Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Agrisera | 07-May-2020 | Biotechnology |
Olink Proteomics Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Agrisera | Biotechnology | Vannas, Sweden |
Olink Proteomics FAQs
-
When was Olink Proteomics founded?
Olink Proteomics was founded in 2004.
-
Who is the founder of Olink Proteomics?
Ulf Landegren Ph.D, Simon Fredriksson Ph.D, Bjorn Ekstrom, and Mats Nilsson Ph.D are the founders of Olink Proteomics.
-
Who is the CEO of Olink Proteomics?
Jon Heimer is the CEO of Olink Proteomics.
-
Where is Olink Proteomics headquartered?
Olink Proteomics is headquartered in Uppsala, Sweden.
-
What is the size of Olink Proteomics?
Olink Proteomics has 707 total employees.
-
What industry is Olink Proteomics in?
Olink Proteomics’s primary industry is Discovery Tools (Healthcare).
-
Is Olink Proteomics a private or public company?
Olink Proteomics is a Private company.
-
What is the current valuation of Olink Proteomics?
The current valuation of Olink Proteomics is
. -
What is Olink Proteomics’s current revenue?
The current revenue for Olink Proteomics is
. -
How much funding has Olink Proteomics raised over time?
Olink Proteomics has raised $292M.
-
Who are Olink Proteomics’s investors?
Beijer Ventures, Green Sands Equity, Nxt2b, Sands Capital, and Summa Equity are 5 of 6 investors who have invested in Olink Proteomics.
-
Who are Olink Proteomics’s competitors?
Standard BioTools, Oxford BioMedica, Luminex, Harvard Bioscience, and Molecular Devices are some of the 13 competitors of Olink Proteomics.
-
When was Olink Proteomics acquired?
Olink Proteomics was acquired on 08-Jul-2024.
-
Who acquired Olink Proteomics?
Olink Proteomics was acquired by Thermo Fisher Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »